Adverse effect of antivaric drugs, inc scler agents, subs

This code signifies an undesirable or harmful reaction experienced by a patient due to medications used to treat varicose veins, including agents that cause sclerosis. The adverse effect is occurring during a subsequent encounter, meaning the initial treatment of the adverse effect has already taken place, and the patient is receiving follow-up care for the ongoing complication.

Use this code when a patient presents for ongoing management or follow-up of a complication directly attributable to antivaricose drugs or sclerosing agents. This includes scenarios such as persistent skin discoloration, ulceration, nerve damage, or other long-term sequelae following initial treatment of an adverse reaction. It is appropriate for encounters where the focus is on monitoring the resolution or progression of the adverse effect.

• Always sequence this code after the code for the specific manifestation of the adverse effect.
• Ensure the documentation clearly indicates the adverse effect is from an antivaricose drug or sclerosing agent and that the encounter is for follow-up care.
• Do not use this code for initial treatment of an adverse effect; a different 7th character would be required.